|
Volumn 74, Issue 7, 2009, Pages 996-999
|
The long-term results of the "Endeavor" stent.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARDIOVASCULAR AGENT;
DRUG DERIVATIVE;
RAPAMYCIN;
ZOTAROLIMUS;
CLINICAL TRIAL;
CORONARY ARTERY OBSTRUCTION;
DRUG ELUTING STENT;
HEART INFARCTION;
HUMAN;
INSTRUMENTATION;
MORTALITY;
MULTICENTER STUDY;
NOTE;
PATIENT SELECTION;
PROSTHESIS;
RISK ASSESSMENT;
THROMBOSIS;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CARDIOVASCULAR AGENTS;
CLINICAL TRIALS AS TOPIC;
CORONARY STENOSIS;
DRUG-ELUTING STENTS;
HUMANS;
MULTICENTER STUDIES AS TOPIC;
MYOCARDIAL INFARCTION;
PATIENT SELECTION;
PROSTHESIS DESIGN;
RISK ASSESSMENT;
SIROLIMUS;
THROMBOSIS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 77449089964
PISSN: None
EISSN: 1522726X
Source Type: Journal
DOI: 10.1002/ccd.22334 Document Type: Note |
Times cited : (1)
|
References (0)
|